showed that dupilumab induces a profound decrease in sIgE levels of several food allergens in adult AD patients with comorbid FA, highlighting the positive effect of blocking IL‐4 and IL‐13 signaling on sIgE levels.5 The gene discussed is IL4; the disease is Alzheimer disease.